[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation...
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Latest
Market size & share revenue was valued at approximately USD 7.9 Billion in 2023 and is expected to reach USD 8.4 Billion in 2024 and is expected to reach around USD 23.5 Billion by 2032, at a CAGR of 12.1% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co. Inc., Bristol Myers Squibb Company, Pfizer Inc., Johnson & Johnson, AbbVie Inc., Clovis Oncology Inc., Teva Pharmaceutical Industries Ltd., Myriad Genetics Inc., Olympus Corporation, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Zai Lab Limited, and others. Austin, TX, USA, March 28, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “ PARP Inhibitors Market Size, Trends and Insights By Type (Olaparib, Rucaparib, Niraparib, Talazoparib, Others), By Application (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others), By En
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca PLC (NASDAQ: AZN) had its price target raised by analysts at BMO Capital Markets from $80.00 to $82.00. They now have an "outperform" rating on the stock.MarketBeat
- Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- AstraZeneca: Strong In A Weak Market [Seeking Alpha]Seeking Alpha
- Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/25/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- AZN's page on the SEC website